Literature DB >> 16261366

Do early injections of bulking agents following radical prostatectomy improve early continence?

T Schneider1, H Sperling, R Rossi, S Schmidt, H Rübben.   

Abstract

Bulking agents belong to the treatment options of stress urinary incontinence in both genders for a long time, but early injection of bulking agents following radical prostatectomy to improve early continence is a new treatment modality and the results of the first years will be presented in this study. From 1996 to 2001, 55 incontinent patients, of whom 44 suffered from post-prostatectomy incontinence (PPI), have been treated by bulking agents in our clinic and evaluated later on, using a semistandardized questionnaire. Mean age was 65.5 years and the mean follow-up was 32 months. Of 44 patients with PPI, 29 suffered from incontinence of the third, 10 from incontinence of the second and 5 from incontinence of the first degree. We examined the influence of transurethral injection of bulking agents on direct postoperative continence (short-term results) and on continence at the time of follow-up (long-term results) (mean 32 month). An improved early continence (short-term result) was achieved in 30 patients. At follow-up, 19 patients were completely dry, 18 reported an improved continence. Especially the time of treatment, referring to radical prostatectomy, had a significant influence on treatment results with better results in the subgroup of 34 patients that have been treated early (mean 23 days) compared to 10 patients that received delayed treatment (mean 26 months) following radical prostatectomy. The preoperative degree of incontinence had a significant influence on short-term results, and not on long-term results. The amount of bulking material and the number of injections had no significant influence on short-term results, but repeated injections resulted in statistically worse long-term results. In summary, early transurethral injection of bulking agents is an effective and minimal invasive therapy option to improve early continence in patients with PPI. Time to improved continence due to training of the sphincter externus muscle cannot be shortened, but the quality of life during this time can be improved. In case of a severe lesion of the sphincteric muscle, continence cannot be improved for a longer period and the results are poor. In these cases, procedures like implantation of an artificial urinary sphincter may be required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261366     DOI: 10.1007/s00345-005-0010-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  10 in total

1.  [Intraurethral Macroplastic injections in the treatment of urinary incontinence after prostatic surgery].

Authors:  H Bugel; C Pfister; L Sibert; O Cappele; A Khalaf; P Grise
Journal:  Prog Urol       Date:  1999-12       Impact factor: 0.915

2.  Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen.

Authors:  L M Shortliffe; F S Freiha; R Kessler; T A Stamey; C E Constantinou
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

3.  Long-term results of transurethral collagen injection in men with intrinsic sphincter deficiency.

Authors:  G J Faerber; T D Richardson
Journal:  J Endourol       Date:  1997-08       Impact factor: 2.942

4.  [Experiences with local collagen injection in male stress incontinence].

Authors:  C Reek; J Noldus; H Huland
Journal:  Urologe A       Date:  1997-01       Impact factor: 0.639

5.  Collagen injections for genuine stress urinary incontinence: patient selection and durability.

Authors:  S Herschorn; S B Radomski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

6.  [Transurethral collagen injection for treatment of urinary stress incontinence].

Authors:  H W Gottfried; S Maier; E Brändle; K Kleinschmidt; R Hautmann
Journal:  Urologe A       Date:  1997-09       Impact factor: 0.639

7.  Adverse prognostic features of collagen injection therapy for urinary incontinence following radical retropubic prostatectomy.

Authors:  F E Martins; C J Bennett; M Dunn; D Filho; T Keller; G Lieskovsky
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

8.  Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence.

Authors:  J M Cummings; J A Boullier; R O Parra
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

9.  Collagen injection therapy for post-prostatectomy incontinence.

Authors:  D N Smith; R A Appell; R R Rackley; J C Winters
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

10.  Collagen injection for intrinsic sphincteric deficiency in men.

Authors:  S R Aboseif; H E O'Connell; A Usui; E J McGuire
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

  10 in total
  5 in total

Review 1.  The treatment of stress incontinence in men: part 2 of a series of articles on incontinence.

Authors:  Christof Börgermann; Albert Kaufmann; Herbert Sperling; Manfred Stöhrer; Herbert Rübben
Journal:  Dtsch Arztebl Int       Date:  2010-07-09       Impact factor: 5.594

2.  The bone-anchor sub-urethral sling for the treatment of iatrogenic male incontinence: subjective and objective assessment after 41 months of mean follow-up.

Authors:  Claudio Giberti; Fabrizio Gallo; Maurizio Schenone; Pierluigi Cortese
Journal:  World J Urol       Date:  2007-11-03       Impact factor: 4.226

3.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23

4.  Current trends in the management of post-prostatectomy incontinence.

Authors:  Joon Chul Kim; Kang Jun Cho
Journal:  Korean J Urol       Date:  2012-08-16

5.  Treatment outcomes of transurethral macroplastique injection for postprostatectomy incontinence.

Authors:  Sin Woo Lee; Jung Hun Kang; Hyun Hwan Sung; U-Seok Jeong; Young-Suk Lee; Minki Baek; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2014-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.